VivekRoyMD

PubMed

• Phase III randomized trial of Thal+ZLD versus ZLD in patients with asymptomatic multiple myeloma - updated results after 18-year follow-up.
  Nadine Abdallah, Thomas E Witzig, Shaji K Kumar, Martha Q Lacy, Suzanne R Hayman, Angela Dispenzieri, Vivek Roy, Morie A Gertz, P Leif Bergsagel, S Vincent Rajkumar> ;Leukemia. 2024 Feb 28
• A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia.
  Parrondo, R., Dutta, N., LaPlant, B., Elliott, J., Fernandez, A., Zimmerman, A., Cicco, G., Han, B., Heslop, K., Chapin, D., Sher, T., Roy, V., Rasheed, A., Das, S., C...> ;British Journal of Haematology. 2024 Jan 29
• Loneliness, immunological recovery patterns, and health-related quality of life (HRQOL) outcomes in patients receiving hematopoietic stem cell transplantation.
  Lange, L., Ames, S., Ames, G., Heckman, M., White, L., Roy, V., Foran, J.> ;BMC Psychology. 2024 Jan 19
• A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients.
  Steven C Ames, Lori Lange, Gretchen E Ames, Michael G Heckman, Launia J White, Vivek Roy, James M Foran> ;Cancer Medicine. 2024 Feb 1
• 1 citations
  Lung Injury Prediction Model in Bone Marrow Transplantation: A Multicenter Cohort Study.
  Herasevich, S., Schulte, P., Hogan, W., Alkhateeb, H., Zhang, Z., Khera, N., Roy, V., Gajic, O., Yadav, H., White, B., Zhang, Z.> ;American Journal of Respiratory and Critical Care Medicine. 2024 Mar 1
• 2 citations
  Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
  Udit Yadav, Shaji K Kumar, Linda B Baughn, Angela Dispenzieri, Patricia Greipp, Rhett Ketterling, Dragan Jevremovic, Francis K Buadi, David Dingli, Martha Q Lacy, Rafa...> ;Blood. 2023 Nov 30
• Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Prelim...
  Saurav Das, Sikander Ailawadhi, Taimur Sher, Vivek Roy, Andre Fernandez, Ricardo D Parrondo> ;Current Oncology. 2023 Oct 31
• The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers.
  Sikander Ailawadhi, Meghna Ailawadhi, Navnita Dutta, Ricardo D Parrondo, Vivek Roy, Taimur Sher, Mizba Baksh, Ahsan Rasheed, Saurav Das, Andre J Fernandez, Aneel Paulu...> ;Cancer Medicine. 2023 Sep 1
• Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation...
  Farah Yassine, Mohamed A Kharfan-Dabaja, Athanasios Tsalantsanis, Vivek Roy, Abba C Zubair, Hemant S Murthy, Ernesto Ayala, Madiha Iqbal, Taimur Sher, Sikander Ailawad...> ;Bone Marrow Transplantation. 2023 Oct 1
• A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
  Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, Prashant Kapoor, Martha Q Lacy, Morie A Gertz, Francis K Buadi, David Dingli, Rahma Warsame, Taxiarchis Kourelis, ...> ;American Journal of Hematology. 2023 Aug 1
• 1 citations
  Post-Autologous Hematopoietic Cell Transplant Care in the "Home Sweet Home" Setting: A Treatment Paradigm Shift.
  Mohamed A Kharfan-Dabaja, Vivek Roy, Hemant Murthy, Deborah Fischer, Razan Mohty, Ashley Greathouse, Alethea Brown, Kathryn Moreno, Emily Godsey, Jennifer M Higginboth...> ;Hematology/oncology and Stem Cell Therapy. 2023 May 23
• Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
  Muhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, Vivek Roy, Taimur Sher, Victoria R Alegria, Rahma M Warsame, Rafael Fonseca, Ahsan Rasheed, Wilson I Gonsa...> ;Anti-Cancer Drugs. 2024 Jan 1
• A Calcineurin Inhibitor Free Graft Versus Host Disease Prophylaxis for Patients Undergoing Matched Related and Matched Unrelated Donor Allogeneic Hematopoietic Cell Tr...
  Madiha Iqbal, Felipe A Mendieta Nieto, Kaitlyn M Brannick, Zhuo Li, Hemant Murthy, James Foran, Vivek Roy, Mohamed A Kharfan-Dabaja, Ernesto Ayala> ;Transplantation and Cellular Therapy. 2023 May 1
• 2 citations
  AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.
  Sikander Ailawadhi, Ricardo D Parrondo, Navnita Dutta, Bing Han, Gina Ciccio, Yesesri Cherukuri, Victoria R Alegria, Betsy R LaPlant, Vivek Roy, Taimur Sher, Brett Edw...> ;Cancers. 2023 Jan 12
• Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study.
  Binod Dhakal, Mei-Jei Zhang, Linda J Burns, Xiaoying Tang, Christa Meyer, Lih-Wen Mau, Ajay K Nooka, Edward Stadtmauer, Ivana N Micallef, Joseph McGuirk, Luciano Costa...> ;Haematologica. 2023 Aug 1
• Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
  Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood Cancer Journal. 2022 Nov 24
• 15 citations
  Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;American Journal of Hematology. 2023 Jan 1
• 2 citations
  Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood. 2022 Nov 3
• 3 citations
  Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience.
  Megan Melody, Sangeetha Gandhi, Hollie Saunders, Zaid Abdel-Rahman, Jacquelyn Hastings, Paula Lengerke Diaz, Nicole Gannon, Tuan Truong, Matthew Hathcock, Arushi Khura...> ;Leukemia & Lymphoma. 2022 Jun 1
• 5 citations
  Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.
  Ricardo D Parrondo, Zaid Abdel Rahman, Michael G Heckman, Mikolaj Wieczorek, Liuyan Jiang, Hassan B Alkhateeb, Mark R Litzow, Patricia Greipp, Taimur Sher, Leif Bergsa...> ;Blood Cancer Journal. 2022 Jun 1
• 4 citations
  Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results.
  Sikander Ailawadhi, Ricardo D Parrondo, Muhamad Alhaj Moustafa, Betsy R LaPlant, Victoria Alegria, Dustin Chapin, Vivek Roy, Taimur Sher, Aneel Paulus, Asher A Chanan-...> ;Hematological Oncology. 2022 Oct 1
• 8 citations
  Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis.
  Ricardo D Parrondo, Keren Sam, Ahsan Rasheed, Victoria Alegria, Taimur Sher, Vivek Roy, Asher Chanan-Khan, Sikander Ailawadhi> ;Blood Cancer Journal. 2022 Apr 19
• Myelomatous ascites and pleural effusion in relapsed multiple myeloma.
  Mizba Baksh, Ke Li, Liuyan Jiang, Victoria Alegria, Taimur Sher, Vivek Roy, Asher Chanan-Khan, Sikander Ailawadhi, Ricardo D Parrondo, Muhamad Alhaj Moustafa> ;Clinical Case Reports. 2022 Feb 1
• 1 citations
  Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature.
  Mizba Baksh, Liuyan Jiang, Victoria Alegria, Taimur Sher, Vivek Roy, Asher Chanan-Khan, Sikander Ailawadhi, Ricardo D Parrondo, Bhatia, U.> ;Clinical Case Reports. 2021 Dec 1
• 10 citations
  Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting
  Thejus T. Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, Kianna Nguyen, Meghna Ailawadhi, Ayesha Samreen, Ricardo D. Parrondo, Taimur Sher, Vivek Roy, Rami Manochakian,...> ;Cancers. 2021 Nov 18
• Join now to see all

Journal Articles

• Targeting CD38 with Daratumumab Is Lethal to Waldenström Macroglobulinaemia Cells  
  Richard Furman, Stephen M Ansell, Sikander Ailawadhi, Thomas E Witzig, Vivek Roy, Taimur Sher, Liuyan Jiang, British Journal of Haematology
• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature

Abstracts/Posters

• Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
  Vivek Roy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Population-Based Analysis of Predictors of Survival and Trends in Outcomes of Elderly Patients with Multiple Myeloma (MM)
  Vivek Roy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Sociodemographic and Clinical Characteristics Associated with PatientÍs Decision to Refuse Multiple Myeloma (MM) Treatment, and Its Impact on Outcomes
  Vivek Roy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Disparities and Their Impact on the Adoption of Health Information Technology (HIT) in Minority Cancer Patients and Caregivers
  Vivek Roy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Trends in Early Mortality from Multiple Myeloma (MM): A Population-Based Analysis
  Vivek Roy, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Computational Modelling of Multiple Myeloma Patient Genomic Signatures to Predict Treatment Outcome 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018